Is methotrexate effective in ankylosing spondylitis?
Roychowdhury
B
B
Bintley-Bagot
S
S
Bulgen
D Y
DY
Thompson
R N
RN
Tunn
E J
EJ
Moots
R J
RJ
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D011336:Probability; D012016:Reference Values; D012720:Severity of Illness Index; D013167:Spondylitis, Ankylosing / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome; D006113:United Kingdom
D018501:Antirheumatic Agents; D008727:Methotrexate